Evaluation of heart fatty acid-binding protein as a biomarker for canine leishmaniosis.
Domingo Casamián-SorrosalRafael Barrera-ChacónSonja FonfaraJosé Ignacio Cristobal-VerdejoJesús Talavera-LópezSilvia Belinchón-LorenzoGuadalupe Miró-CorralesAlicia Caro-VadilloFrancisco Javier DuquePublished in: The Veterinary record (2023)
HFABPc is not consistently elevated in dogs with CanL and is not associated with the severity of the disease, or most echocardiographic or clinicopathological variables studied. The correlation with globulin and HCT was not strong and not considered clinically significant. HFABPc lacks sufficient predictive capacity in dogs with CanL, discouraging further research or clinical use of this biomarker in this disease.